Dexamethasone Eluting Cochlear Implant: a Pivotal Study
Conditions: Cochlear Implant Interventions: Device: Cochlear Implant Sponsors: MED-EL Elektromedizinische Ger äte GesmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Study of MK-5684 Versus Alternative NHA in mCRPC (MK-5684-003)
Conditions: Prostate Cancer Metastatic Interventions: Drug: MK-5684; Drug: Abiraterone acetate; Drug: Enzalutamide; Drug: Hydrocortisone; Drug: Fludrocortisone acetate; Drug: Prednisone; Drug: Dexamethasone Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Intraoperative Autonomic Neural Blockade
Conditions: Pain, Postoperative; Nausea, Postoperative; Vomiting, Postoperative; Analgesia; Opioid Use Interventions: Drug: Local anesthetic injection Bupivacaine plus dexamethasone; Drug: Local anesthetic injection bupivacainde plus dexamethasone plus a colloid; Drug: Local anesthetic injection bupivacaine plus clonidine Sponsors: Universidad Sim ón Bolívar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
A Study of MK-5684 in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)
Conditions: Prostatic Neoplasms; Metastatic Castration-Resistant Prostate Cancer Interventions: Drug: MK-5684; Drug: Dexamethasone; Drug: Fludrocortisone; Drug: Hydrocortisone Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
A Study of MK-5684 Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC); Prostatic Neoplasms Interventions: Drug: MK-5684; Drug: Dexamethasone; Drug: Fludrocortisone acetate; Drug: Hydrocortisone; Drug: Abiraterone acetate; Drug: Prednisone acetate; Drug: Enzalutamide Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Conditions: Low Grade Glioma; Malignant Brain Glioma; Malignant Brain Neoplasm; Meningioma Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Dexamethasone; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration Sponsors: Emory University; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Dexmedetomidine, Ozone and Dexamethasone Local Injection in Carpal Tunnel Syndrome for Pain Relief
Conditions: Carpal Tunnel; Dexmedetomidine; Ozone; Dexamethasone Interventions: Drug: Dexmedetomidine; Drug: Ozone; Drug: Dexamethasone Sponsors: Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
TAP Block With Methyl-prednisolone as a Pain Treatment Modality After Total Abdominal Hysterectomy Procedures
Conditions: Local Anesthetic; Ultrasound; Pain, Acute Interventions: Drug: TAPB with dexamethasone as an adjuvant to local anesthetics; Drug: TAPB with methylprednisolone as an adjuvant to local anesthetics Sponsors: Kasr El Aini Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery
Conditions: Inflammation Eye; Pain, Postoperative; Cataract Interventions: Drug: Dexamethasone Ophthalmic Suspension; Other: Vehicle of OCS-01 Sponsors: Oculis; ORA, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Dexamethasone/Pancreatic Clamp P & F
Conditions: Insulin Resistance; Prediabetic State; Non-Alcoholic Fatty Liver Disease; Overweight and Obesity Interventions: Drug: Insulin human; Drug: Octreotide Acetate; Drug: Glucagon; Drug: Human Growth Hormone; Drug: Dexamethasone Oral; Other: [6,6-2H2] D-glucose; Drug: 20% D-glucose (aq); Dietary Supplement: BOOST Plus; Device: Harvard Apparatus PHD ULTRA CP syringe pump; Device: Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer; Other: Normal saline; Other: Human albumin Sponsors: Columbia University; Albert Einstein College of Medicine; National Institute of Diabetes and Digestive and Kidne...
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
The Use of Submucosal Dexamethasone After Periodontal Surgery
Conditions: Periodontal Pocket; Pain; Swelling/ Edema; Patient Satisfaction; Periodontitis Interventions: Procedure: Periodontal flap surgery with submucosal 8 mg (2 mL) dexamethasone application; Procedure: Periodontal flap surgery with submucosal 2 mL 0.9% isotonic sodium chloride application Sponsors: Yuzuncu Y ıl University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
U.S. Guided Erector Spinae Block for Postoperative Pain Management in Paraumbilical Hernia Repair Patients
Conditions: Regional Anesthesia Interventions: Drug: Bubpivacaine; Drug: dexamethasone; Drug: fentanyl Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment
Conditions: Cancer Interventions: Drug: Dexamethasone; Drug: H1 Antihistaminics Sponsors: Erasmus Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma in Relapse; Multiple Myeloma, Refractory Interventions: Drug: Venetoclax Sponsors: Oncotherapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Study of MK-5684 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)
Conditions: Prostatic Neoplasms; Metastatic Castration-Resistant Prostate Cancer Interventions: Drug: MK-5684; Drug: Dexamethasone; Drug: Fludrocortisone acetate; Drug: Hydrocortisone Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
